Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. MH

Go back to Relmada Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results
(NASDAQ: RLMD) Delayed: 6.65 +0.13 (1.99%)
Previous Close $6.52    52 Week High $4.10 
Open $6.55    52 Week Low $0.87 
Day High $6.95    P/E N/A 
Day Low $6.51    EPS $0.00 
Volume 1,127,915